TrialAnnals of the rheumatic diseases2009

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

E C Keystone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.